Skip to content

Assessing the Effects of Increased Mitochondrial Function Exercise Training on Muscle Performance

Assessing the Effects of Increased Mitochondrial Function and Chronic Aerobic or Resistance Exercise Training on Skeletal Muscle Performance in Older Men; a Pilot Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03325491
Acronym
Rejuvenate2
Enrollment
2
Registered
2017-10-30
Start date
2018-03-07
Completion date
2019-09-16
Last updated
2019-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired Mitochondrial Function, Muscle Performance

Brief summary

As people grow older skeletal muscle gradually becomes smaller and weaker, causing reduced mobility and quality of life. To understand and reverse this negative process investigators need to find new ways of improving the ability of muscle to perform physical activity. There is some evidence that supplements may improve how the mitochondria work, and investigators want to explore this idea in more detail. This is possible by measuring how the muscles work and respond to exercise before and after taking the supplement alongside an aerobic (i.e. cycling) and resistance (i.e. weight lifting) exercise programme. This will give us the basic information investigators would need to see if this is a useful idea.

Interventions

DIETARY_SUPPLEMENTAcipimox

Acipimox plus exercise training: Oral supplement containing Acipimox 250mgs as the active ingredient in blinded label tablet form.

DIETARY_SUPPLEMENTPlacebo

Alternate unilateral resistance and aerobic exercise training will also be performed 5 times per week for 6 weeks.

Sponsors

Royal Devon and Exeter NHS Foundation Trust
CollaboratorOTHER
University of Exeter
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
65 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Male * Age between 65-75 years * Body mass index between 19-29 * No active cardiovascular or metabolic disease * No active respiratory disease * No current musculoskeletal injuries * A sedentary lifestyle (i.e. does not engage in strenuous, planned physical activity) * The ability to give informed consent

Exclusion criteria

* Currently taking a statin drug or NSAIDs * Have a current peptic ulcer * Have any renal impairment * Have a known hypersensitivity to Acipimox * Suffer from vertigo * Smoker

Design outcomes

Primary

MeasureTime frameDescription
Change in mitochondrial functionBaseline, 3 weeks, 6 weeksMitochondria will be extracted from muscle samples immediately post-biopsy (biopsies taken baseline, week 3 and week 6) and analysed for content and subsequently for oxidative respiratory function using the Oroboros technique, and maximal rates of Adenosine Triphosphate (ATP) production.

Secondary

MeasureTime frameDescription
Chronic changes in habitual muscle protein synthetic ratesBaseline, 3 weeks and 6 weeksBaseline saliva samples then frequent saliva samples over 6 weeks following oral ingestion of the stable isotope deuterium oxide (D2O, or 'heavy water') will be analysed by gas-chromatography-pyrolysis-isotope ratio mass-spectrometry. analysis. Muscle samples collected at baseline, 3 weeks, 6 weeks will also be analysed by gas-chromatography-pyrolysis-isotope ratio mass-spectrometry

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026